CliffBio
small molecule

PREVDUO

GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE

Loss of exclusivityOctober 2038latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand namePREVDUO
Active ingredientGLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE
Strength0.6MG/3ML (0.2MG/ML);3MG/3ML (1MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalFebruary 2023
Marketing statusRX

Listed patents

PatentExpiresType
11110054October 2038product
11938217October 2038product
10456354October 2038product
12151020October 2038product
12383491October 2038product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PREVDUO patent cliff — loss of exclusivity October 2038 | CliffBio